This Article Full Text Full Text (PDF) All Versions of this Article: 144/10/4544    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tao, Y.-X. Articles by Segaloff, D. L. Search for Related Content PubMed PubMed Citation Articles by Tao, Y.-X. Articles by Segaloff, D. L.

Functional Characterization of Melanocortin-4 Receptor Mutations Associated with Childhood Obesity

Department of Physiology and Biophysics, The University of Iowa, Iowa City, Iowa 52242

Address all correspondence and requests for reprints to: Ya-Xiong Tao, Ph.D., Department of Physiology and Biophysics, 5-471 Bowen Science Building, The University of Iowa, Iowa City, Iowa 52242. E-mail: ya-xiong-tao{at}uiowa.edu.

The melanocortin-4 receptor (MC4R) is a member of the rhodopsin-like G protein-coupled receptor family. The binding of -MSH to the MC4R leads to increased cAMP production. Recent pharmacological and genetic studies have provided compelling evidence that MC4R is an important regulator of food intake and energy homeostasis. Allelic variants of MC4R were reported in some children with early-onset severe obesity. However, few studies have been performed to confirm that these allelic variants result in an impairment of the receptor’s function. In this study, we expressed wild-type and variant MC4Rs in HEK293 cells and systematically studied ligand binding, agonist-stimulated cAMP, and cell surface expression. Six of the 11 mutants examined had either decreased (S58C, N62S, Y157S, C271Y) or no (P78L, G98R) ligand binding, with proportional impairments in [Nle⁴, D-Phe⁷]--MSH-stimulated cAMP production. Confocal microscopy confirmed that the observed decreases in hormone binding by these mutants are associated with decreased cell surface expression due to intracellular retention of the mutants. The other five allelic variants (D37V, P48S, V50M, I170V, N274S) were found to be expressed at the cell surface and to bind agonist and respond with increased cAMP production normally. The data on these latter five variants raise the question as to whether they are indeed causative of the obesity or not and, if so, by what mechanism. Our data, therefore, stress the importance of characterizing the properties of MC4R variants associated with early-onset severe obesity. We further propose a classification scheme for mutant MC4Rs based upon their properties.

This article has been cited by other articles:

				Z.-C. Fan, J. L Sartin, and Y.-X. Tao Molecular cloning and pharmacological characterization of porcine melanocortin-3 receptor J. Endocrinol., January 1, 2008; 196(1): 139 - 148. [Abstract] [Full Text] [PDF]

				C. Staubert, P. Tarnow, H. Brumm, C. Pitra, T. Gudermann, A. Gruters, T. Schoneberg, H. Biebermann, and H. Rompler Evolutionary Aspects in Evaluating Mutations in the Melanocortin 4 Receptor Endocrinology, October 1, 2007; 148(10): 4642 - 4648. [Abstract] [Full Text] [PDF]

				P. M. Conn, A. Ulloa-Aguirre, J. Ito, and J. A. Janovick G Protein-Coupled Receptor Trafficking in Health and Disease: Lessons Learned to Prepare for Therapeutic Mutant Rescue in Vivo Pharmacol. Rev., September 1, 2007; 59(3): 225 - 250. [Abstract] [Full Text] [PDF]

				J. D. Ahn, B. Dubern, C. Lubrano-Berthelier, K. Clement, and G. Karsenty Cart Overexpression Is the Only Identifiable Cause of High Bone Mass in Melanocortin 4 Receptor Deficiency Endocrinology, July 1, 2006; 147(7): 3196 - 3202. [Abstract] [Full Text] [PDF]

				Y.-X. Tao and D. L. Segaloff Functional Analyses of Melanocortin-4 Receptor Mutations Identified from Patients with Binge Eating Disorder and Nonobese or Obese Subjects J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5632 - 5638. [Abstract] [Full Text] [PDF]

				K. A. Beaumont, R. A. Newton, D. J. Smit, J. H. Leonard, J. L. Stow, and R. A. Sturm Altered cell surface expression of human MC1R variant receptor alleles associated with red hair and skin cancer risk Hum. Mol. Genet., August 1, 2005; 14(15): 2145 - 2154. [Abstract] [Full Text] [PDF]

				L. Ma, P. A. Tataranni, C. Bogardus, and L. J. Baier Melanocortin 4 Receptor Gene Variation Is Associated With Severe Obesity in Pima Indians Diabetes, October 1, 2004; 53(10): 2696 - 2699. [Abstract] [Full Text] [PDF]

				A Dempfle, A Hinney, M Heinzel-Gutenbrunner, M Raab, F Geller, T Gudermann, H Schafer, and J Hebebrand Large quantitative effect of melanocortin-4 receptor gene mutations on body mass index J. Med. Genet., October 1, 2004; 41(10): 795 - 800. [Full Text] [PDF]

				Y.-X. Tao and D. L. Segaloff Functional Characterization of Melanocortin-3 Receptor Variants Identify a Loss-of-Function Mutation Involving an Amino Acid Critical for G Protein-Coupled Receptor Activation J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3936 - 3942. [Abstract] [Full Text] [PDF]

				D. Mizrachi and D. L. Segaloff Intracellularly Located Misfolded Glycoprotein Hormone Receptors Associate with Different Chaperone Proteins than Their Cognate Wild-Type Receptors Mol. Endocrinol., July 1, 2004; 18(7): 1768 - 1777. [Abstract] [Full Text] [PDF]

				P. A. Donohoue, Y.-X. Tao, M. Collins, G. S. H. Yeo, S. O'Rahilly, and D. L. Segaloff Deletion of Codons 88-92 of the Melanocortin-4 Receptor Gene: A Novel Deleterious Mutation in an Obese Female J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5841 - 5845. [Abstract] [Full Text] [PDF]